Regulation of androgen receptor activity by tyrosine phosphorylation.

Cited by (364)

Items 201–300 of 364

  1. Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives
    Jieping Hu, Gongxian Wang, Ting Sun · 2017 · Tumor Biology
  2. A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer
    Anne Yvonne Warren, Charles E. Massie, Kate Watt, Katarina Luko, Folake A. Orafidiya, Luke A. Selth, Hisham Mohammed, Brinder S. Chohan, Suraj Menon, Ajoeb Baridi et al. · 2018 · Oncogene
  3. Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA−/lo castration-resistant cells
    Kiera Rycaj, Eun Jeong Cho, Xin Liu, Hsueh‐Ping Chao, Bigang Liu, Qiuhui Li, Ashwini K. Devkota, Dingxiao Zhang, Xin Chen, John Moore et al. · 2016 · Oncotarget
  4. From Therapy Resistance to Targeted Therapies in Prostate Cancer
    Filipa Moreira‐Silva, Rui Henrique, Cármen Jerónimo · 2022 · Frontiers in Oncology
  5. Predicting puberty in partial androgen insensitivity syndrome: Use of clinical and functional androgen receptor indices
    Ngee Lek, Rieko Tadokoro‐Cuccaro, Jonathan B. Whitchurch, Bismoy Mazumder, Harriet L. Miles, Philippa M. Prentice, Trevor Bunch, Karolina A. Zielińska, Veronika Maria Metzler, Nigel Patrick Mongan et al. · 2018 · EBioMedicine
  6. Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy
    Madoka Iida, Kentaro Sahashi, Naohide Kondo, Hideaki Nakatsuji, Genki Tohnai, Yutaka Tsutsumi, Seiya Noda, Ayuka Murakami, Kazunari Onodera, Yohei Okada et al. · 2019 · Nature Communications
  7. Testicular descent: A review of a complex, multistaged process to identify potential hidden causes of UDT
    Gulcan Sarila, John Medwyn Hutson, Jaya Vikraman · 2021 · Journal of Pediatric Surgery
  8. Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel
    John C. Araujo, Trudel, Paliwal Paliwal · 2013 · Cancer Management and Research
  9. Androgen receptor splicing variant 7: Beyond being a constitutively active variant
    Chen Shao, Bingbing Yu, Yanan Liu · 2019 · Life Sciences
  10. Enhanced Prediction of Src Homology 2 (SH2) Domain Binding Potentials Using a Fluorescence Polarization-derived c-Met, c-Kit, ErbB, and Androgen Receptor Interactome
    Kin K. Leung, Ronald J. Hause, John L. Barkinge, Mark F. Ciaccio, Chih‐Pin Chuu, Richard Baker Jones · 2014 · Molecular & Cellular Proteomics
  11. A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
    Sébastien Taurin, Monica Archibald, Tara Pritchard, Hayley L. Nehoff, Rhonda J. Rosengren, Khaled F. Greish · 2016 · International Journal of Nanomedicine
  12. Dietary palmitate cooperates with Src kinase to promote prostate tumor progression
    Sungjin Kim, Xiangkun Yang, Amelia Yin, Junyi Zha, Zanna M. Beharry, Aiping Bai, Alicja E. Bielawska, Michael G. Bartlett, Hang Yin, Houjian Cai · 2019 · The Prostate
  13. Cancer Stem Cells and Androgen Receptor Signaling: Partners in Disease Progression
    Juan Carlos Quintero, Néstor Fabián Díaz, Mauricio Rodríguez‐Dorantes, Ignacio Camacho‐Arroyo · 2023 · International Journal of Molecular Sciences
  14. The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy
    Michael V. Fiandalo, Wenjie Wu, James Lloyd Mohler · 2013 · Current Drug Targets
  15. Kinase Modulation of Androgen Receptor Signaling: Implications for Prostate Cancer
    Kalpit Shah, Neil A. Bradbury · 2015 · Cancer Cell & Microenvironment
  16. Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models
    Anna Tesei, Carlo Leonetti, Marzia Di Donato, Elisa Gabucci, Manuela Porru, Greta Varchi, Andrea Guerrini, Dino Amadori, Chiara Arienti, Sara Pignatta et al. · 2013 · PLoS ONE
  17. Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patients
    Fatma Zakaria, Nehal Mohamed Elmashad, Dareen Mohamed · 2015 · Alexandria Journal of Medicine
  18. Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors
    Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, Sandrine Michel, Éva Erdmann, Gonzague Du Bouexic De Pinieux, Florence Cabon, Jean‐Pierre Bergerat, Marie‐France Poupon et al. · 2012 · PLoS ONE
  19. Intracellular adaptor molecules and AR signalling in the tumour microenvironment
    Vikash Reebye, Andrea Frilling, Nagy Adley Habib, Paul J. Mintz · 2010 · Cellular Signalling
  20. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression
    Qianjin Li, Lishann M. Ingram, Sungjin Kim, Zanna M. Beharry, Jonathan A. Cooper, Houjian Cai · 2018 · Neoplasia
  21. Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice
    Min Wu, Sahn‐Ho Kim, Indrani Datta, Albert M. Levin, Gregory E. Dyson, Jing Li, Stephanie Kaypee, Mahadeva M. M. Swamy, Nilesh Gupta, Ho Jeong Kwon et al. · 2015 · Oncotarget
  22. Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer
    Takahiro Inoue, Osamu Ogawa · 2011 · Prostate Cancer
  23. Mutation of Androgen Receptor N-Terminal Phosphorylation Site Tyr-267 Leads to Inhibition of Nuclear Translocation and DNA Binding
    Mehmet Karaca, Yuanbo Liu, Zhentao Zhang, Dinuka De Silva, Joel S. Parker, Henry Shelton Earp, Young E. Whang · 2015 · PLoS ONE
  24. CrkI and p130Cas complex regulates the migration and invasion of prostate cancer cells
    Yuanqing Dai, Lin Qi, Xiaobo Zhang, Yuan Li, Minfeng Chen, Xiongbing Zu · 2011 · Cell Biochemistry and Function
  25. Androgen receptor regulates SRC expression through microRNA-203
    Man Kit Siu, Wei‐Yu Chen, Hong‐Yuan Tsai, Hsiu-Lien Yeh, Juan Juan Yin, Shih-Yang Liu, Yen‐Nien Liu · 2016 · Oncotarget
  26. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications
    Lance Edward V. Lumahan, Mazia Arif, Amy E. Whitener, Ping Yi · 2024 · Cells
  27. Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling
    Xiong Zhang, Zenghong Huang, Junjian Wang, Zhao Ma, Joy C. Yang, Eva Corey, Christopher P. Evans, Ai‐Ming Yu, Hong-Wu Chen · 2021 · Cancers
  28. Emerging biological observations in prostate cancer
    Shreya Shah, Eric Jay Small · 2009 · Expert Review of Anticancer Therapy
  29. Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling
    Maryam Ghotbaddini, Keyana Cisse, Alexis Erasta Carey, Joann B. Powell · 2017 · PLoS ONE
  30. Kindlin-2 promotes Src-mediated tyrosine phosphorylation of androgen receptor and contributes to breast cancer progression
    Luyao Ma, Ye-Teng Tian, Tao Qian, Wen-Jun Li, Cheng-Min Liu, Bi-Zhu Chu, Qian Kong, Renwei Cai, Panzhu Bai, Lisha Ma et al. · 2022 · Cell Death and Disease
  31. Beyond Androgen Deprivation
    Mark Frederick McCarty, Jalal Hejazi, Reza Rastmanesh · 2014 · Integrative Cancer Therapies
  32. Androgen-Sensitive Microsomal Signaling Networks Coupled to the Proliferation and Differentiation of Human Prostate Cancer Cells
    Harryl D. Martinez, Jordy J. Hsiao, Rohini J Jasavala, Izumi V. Hinkson, Jimmy K. Eng, Michael E. Wright · 2011 · Genes & Cancer
  33. MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2
    Xinbo Sun, Yongwei Chen, Qisheng Yao, Xuhua Chen, Min Yi He, Congbo Chen, Yong Yang, Xiaoxin Gong, Li Huang · 2021 · Technology in Cancer Research & Treatment
  34. Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
    Paula O. Cooper, Jiang Yang, Hsing‐Hui Wang, Meaghan Maureen Broman, Shyaman Jayasundara, Subhransu S. Sahoo, Bingyu Yan, Gada D. Awdalkreem, Gregory M. Cresswell, Liang Wang et al. · 2024 · Communications Biology
  35. Characterization of the Phosphoproteome in Androgen-Repressed Human Prostate Cancer Cells by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
    Xu Wang, Paul A. Stewart, Qiang Cao, Qing‐Xiang Amy Sang, Leland W.K. Chung, Mark R. Emmett, Alan G. Marshall · 2011 · Journal of Proteome Research
  36. Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5
    Kersten Berndt, Marcus Kim, Andreas Meinhardt, Jörg Klug · 2007 · Molecular and Cellular Biochemistry
  37. The Role of Crosstalk between AR3 and E2F1 in Drug Resistance in Prostate Cancer Cells
    Jin Xu, Xi Yang, Dhanraj Deshmukh, Hegang Chen, Shengyun Fang, Yun Qiu · 2020 · Cells
  38. Src controls castration recurrence of CWR 22 prostate cancer xenografts
    Bing Su, Bryan M. Gillard, Lingqiu Gao, Kevin Hasegawa Eng, Irwin H. Gelman · 2013 · Cancer Medicine
  39. Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass
    Chih-Cheng Yang, Ladan Fazli, Salvatore Loguercio, Irina L. Zharkikh, Pedro Aza‐Blanc, Martin Edwin Gleave, Dieter A Wolf · 2015 · Oncotarget
  40. X-linked genetic risk factors that promote autoimmunity and dampen remyelination are associated with multiple sclerosis susceptibility
    Kirill Borziak, Joseph Finkelstein · 2022 · Multiple Sclerosis and Related Disorders
  41. G‐protein alpha‐s and ‐12 subunits are involved in androgen‐stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells
    Jianjun Liu, Hyewon Youn, Jun Yang, Ningchao Du, Jihong Liu, Hongwei Liu, Benyi Li · 2011 · The Prostate
  42. Constitutive Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Progression
    Joann B. Powell · 2018 · Journal of Cancer Treatment and Diagnosis
  43. Interaction between androgen receptor and coregulator SLIRP is regulated by Ack1 tyrosine kinase and androgen
    Dinuka De Silva, Zhentao Zhang, Yuanbo Liu, Joel S. Parker, Chenxi Xu, Ling Cai, Gang Greg Wang, Henry Shelton Earp, Young E. Whang · 2019 · Scientific Reports
  44. AR-dependent phosphorylation and phospho-proteome targets in prostate cancer
    Varadha Balaji Venkadakrishnan, Salma Ben‐Salem, Hannelore V. Heemers · 2020 · Endocrine Related Cancer
  45. New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
    Abhijit M. Godbole, Vincent C.O. Njar · 2011 · Prostate Cancer
  46. Regulation of p27 (Kip1) by Ubiquitin E3 Ligase RNF6
    Dhanraj Deshmukh, Jin Xu, Xi Yang, Hermela Shimelis, Shengyun Fang, Yun Qiu · 2022 · Pharmaceutics
  47. The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression
    Lin Gao, Bo Han, Xuesen Dong · 2022 · Frontiers in Oncology
  48. The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer
    Chiara Ciccarese, Elisabetta Nobili, Donatella Grilli, Laura Casolari, Karim Rihawi, Francesco Gelsomino, Giampaolo Tortora, Francesco Massari · 2016 · Expert Review of Anticancer Therapy
  49. Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity
    Manqi Zhang, Egla Suarez, Judy L. Vasquez, Lubov Nathanson, Leif E. Peterson, Kimal Rajapakshe, Paul Basil, Nancy L. Weigel, Cristian Coarfa, Irina U. Agoulnik · 2018 · Oncogene
  50. Ecdysone receptor and ultraspiracle proteins are tyrosine phosphorylated during adult development of silkmoths
    S. Sridhara · 2011 · Insect Biochemistry and Molecular Biology
  51. N-terminal domain of the androgen receptor contains a region that can promote cytoplasmic localization
    Javid A. Dar, Kurtis Eisermann, Khalid Zaffar Masoodi, Junkui Ai, Dan Wang, Tyler S. Severance, Sharanya D. Sampath-Kumar, Zhou Wang · 2013 · The Journal of Steroid Biochemistry and Molecular Biology
  52. Fatty Acids and Calcium Regulation in Prostate Cancer
    Ivan V. Maly, Wilma A. Hofmann · 2018 · Nutrients
  53. The Expression of Androgen Receptor and Its Variants in Human Prostate Cancer Tissue according to Disease Status, and Its Prognostic Significance
    Sung‐Woo Park, Jung Hee Kim, Hyun Jung Lee, Dong‐Hoon Shin, Sang Don Lee, Sik Yoon · 2018 · The World Journal of Men s Health
  54. Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancer
    Vikash Reebye, Charlotte Lynne Bevan, Mahrokh Nohadani, Amin Hajitou, Nagy Adley Habib, Paul J. Mintz · 2010 · Cellular Signalling
  55. Molecular genetic mechanisms of drug resistance in prostate cancer
    George Sergeevich Krasnov, Alexey Alexandrovich Dmitriev, А. Ф. Садритдинова, Н. Н. Волченко, Elena N. Slavnova, Т. В. Данилова, Anastasiya V. Snezhkina, Nataliya V. Melnikova, Maria Fedorova, Valentina A. Lakunina et al. · 2015 · Molecular Biology
  56. Молекулярно-генетические механизмы формирования лекарственной устойчивости при терапии рака предстательной железы
    George Sergeevich Krasnov, Alexey Alexandrovich Dmitriev, А. Ф. Садритдинова, Н. Н. Волченко, Elena N. Slavnova, Т. В. Данилова, Anastasiya V. Snezhkina, Nataliya V. Melnikova, Maria Fedorova, Valentina A. Lakunina et al. · 2015 · Molecular Biology
  57. New developments in the treatment of castration resistant prostate cancer
    DanielP Petrylak, Roxanne Jimmy Wadia · 2014 · Asian Journal of Andrology
  58. Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells
    Yan Ding, Xiaoling Wang, Aihui Xu, Xia Xu, Keli Tian, Charles Y.F. Young, Huiqing Yuan · 2010 · Journal of Cellular Biochemistry
  59. Analysis of origin and protein-protein interaction maps suggests distinct oncogenic role of nuclear EGFR during cancer evolution
    Ainur Sharip, Diyora Abdukhakimova, Xiao Wang, Alexey Kim, Yevgeniy Kim, Aigul Sharip, Askarbek N Orakov, Lixia Miao, Qing-lei Sun, Yue Chen et al. · 2017 · Journal of Cancer
  60. Research Resource: Androgen Receptor Activity Is Regulated Through the Mobilization of Cell Surface Receptor Networks
    Jordy J. Hsiao, Brandon H. Ng, Melinda M. Smits, Harryl D. Martinez, Rohini J Jasavala, Izumi V. Hinkson, Damian Fermin, Jimmy K. Eng, Alexey I. Nesvizhskii, Michael E. Wright · 2015 · Molecular Endocrinology
  61. AR Structural Variants and Prostate Cancer
    Laura Cato, Maysoun Shomali · 2022 · Advances in experimental medicine and biology
  62. Recepteur d'origine nantais (RON), more than a kinase: Role in castrate‐resistant prostate cancer
    Izhar Singh Batth, Huiyoung Yun, Addankl P. Kumar · 2015 · Molecular Carcinogenesis
  63. Therapeutic Modulation of Prostate Cancer Metastasis
    Sankar Narayan Krishna, Raymond C. Bergan · 2014 · Future Medicinal Chemistry
  64. Synthesis, Anticancer Activity and Computational SAR Analysis of Acylsulfonylpiperazines Derivatives
    Zohra Benfodda, Vanessa Fritz, Corinne Henriquet, Caterina Fattorusso, Gerardo Cebrián‐Torrejón, Marco Persico, Antonio Di Dato, Marialuisa Menna, H. Blancou, Lluis Fajas A · 2017 · Medicinal Chemistry
  65. The role of SRC family kinases in prostate cancer.
    Oleg Tatarov, Joanne Edwards · 2007 · Europe PMC (PubMed Central)
  66. Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells
    Takahiro Inoue, Takashi Kobayashi, N. Terada, Y. Shimizu, T. Kamoto, O. Ogawa, Eijiro Nakamura · 2007 · Expert Review of Endocrinology & Metabolism
  67. PDIA2 has a dual function in promoting androgen deprivation therapy induced venous thrombosis events and castrate resistant prostate cancer progression
    Yinan Li, Lei Lv, Meng Ye, Ning Xie, Ladan Fazli, Yuli Wang, Weilun Wang, Shuofei Yang, Qihong Ni, Jiaquan Chen et al. · 2024 · Oncogene
  68. Is there any clinical relevant difference between non mosaic Klinefelter Syndrome patients with or without Androgen Receptor variations?
    Umberto Valente, Cinzia Vinanzi, Savina Dipresa, Riccardo Selice, Massimo Menegazzo, Massimo Iafrate, Carlo Foresta, Andrea Garolla · 2017 · Scientific Reports
  69. Proteomic analysis of the androgen receptor via MS‐compatible purification of biotinylated protein on streptavidin resin
    Ryan J. Austin, Heidi M. Smidansky, Carly A. Holstein, Deborah K. Chang, Angela Epp, Neil C. Josephson, Daniel B. Martin · 2011 · PROTEOMICS
  70. The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2
    Christine Helsen, Tien T. Nguyen, Thomas Vercruysse, Staf M. L. Wouters, Dirk Daelemans, Arnout R. D. Voet, Frank Claessens · 2022 · International Journal of Molecular Sciences
  71. Maternal Protein Restriction Alters the Expression of Proteins Related to the Structure and Functioning of the Rat Offspring Epididymis in an Age-Dependent Manner
    Marília Martins Cavariani, Talita de Mello Santos, Luiz Gustavo de Almeida Chuffa, Patrícia Fernanda Felipe Pinheiro, Wellerson Rodrigo Scarano, Raquel Fantin Domeniconi · 2022 · Frontiers in Cell and Developmental Biology
  72. The positive relationship between androgen receptor splice variant-7 expression and the risk of castration-resistant prostate cancer: A cumulative analysis
    Shankun Zhao, Jian Liao, Shilong Zhang, Maolei Shen, Xin Li, Libo Zhou · 2023 · Frontiers in Oncology
  73. p130Cas is required for androgen-dependent postnatal development regulation of submandibular glands
    Jing Gao, Aonan Li, Shinsuke Fujii, Fei Huang, Chihiro Nakatomi, Ichiro Nakamura, Hiroaki Honda, Tamotsu Kiyoshima, Eijiro Jimi · 2023 · Scientific Reports
  74. Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
    Ralph E. White, Maxwell Henry Bannister, Abderrahman Day, Hannah E. Bergom, Victor M. Tan, Justin H. Hwang, Hai Dang Nguyen, Justin M. Drake · 2023 · Frontiers in Oncology
  75. PKSPS: a novel method for predicting kinase of specific phosphorylation sites based on maximum weighted bipartite matching algorithm and phosphorylation sequence enrichment analysis
    Xinyun Guo, Huan He, Jialin Yu, Shaoping Shi · 2021 · Briefings in Bioinformatics
  76. More Than Androgens: Hormonal and Paracrine Signaling in Prostate Development and Homeostasis
    Juliana Felgueiras, Vânia Camilo, Margarida Fardilha, Cármen Jerónimo · 2020 · Springer eBooks
  77. Androgen receptor post-translational modifications and their implications for pathology
    Inés Montoya-Novoa, José Luis Gardeazábal-Torbado, Andrea Alegre‐Martí, Pablo Fuentes‐Prior, Eva Estébanez‐Perpiñá · 2024 · Biochemical Society Transactions
  78. Fibroblasts promote the progression of benign prostatic hyperplasia through colony-stimulating factor 1 receptor-mediated RTK signaling in prostatic epithelial cells
    Ming Zhan, Ruifeng Yang, Yue Gu, Jun Zhu, Miaomiao Guo, George Pupwe, Xiaohua Huang, Huan Xu, Zhilian Jia, Kyle Takehiro et al. · 2025 · Molecular Biomedicine
  79. Tissue Levels of Androgens in Castration-Recurrent Prostate Cancer
    James Lloyd Mohler, Mark Anton Titus · 2009 · Springer eBooks
  80. Convergence of EGF Receptor and Src Family Signaling Networks in Cancer
    Jessica E. Pritchard, Allison B. Jablonski, Sarah J. Parsons · 2008 · Humana Press eBooks
  81. Insights from AR Gene Mutations
    Grant Buchanan, Eleanor F. Need, Tina Bianco‐Miotto, Norman M. Greenberg, Howard I. Scher, Margaret M. Centenera, Lisa M. Butler, Diane M. Robins, Wayne D. Tilley · 2009 · Springer eBooks
  82. Role of Androgens in Abiraterone Resistance
    Giuseppe A. Colloca · 2012 · Journal of Clinical Oncology
  83. Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance
    Shuai Gao, Nolan D. Patten, Changmeng Cai · 2025 · Journal of the National Cancer Center
  84. Antifolate/folate-activated HGF/c-Met signalling pathways in mouse kidneys—the putative role of their downstream effectors in cross-talk with androgen receptor
    Magdalena Dudkowska, Seweryn Bajer, Tomasz Jaworski, Joanna Zielińska, M Manteuffel-Cymborowska, Barbara Grzelakowska-Sztabert · 2008 · Archives of Biochemistry and Biophysics
  85. Systematic Assessment of Protein C-Termini Mutated in Human Disorders
    Zachary T. FitzHugh, Martin R. Schiller · 2023 · Biomolecules
  86. Cell Biology of Prostate Cancer and Molecular Targets
    Martin Edwin Gleave, Michael Cox, Yuzhuo Z. Wang · 2010 · Springer eBooks
  87. Truncated Androgen Receptor Splice Variants in Prostate Cancer
    Peter Eoin Lonergan, Donald J. Tindall · 2013 · Springer eBooks
  88. Tumor Promoting Aspects of Senescence in Cancer Progression
    Qing Yang, Yingqiu Xie, Lixia Miao · 2016 · Cancer Investigation
  89. Coregulators and the Regulation of Androgen Receptor Action in Prostate Cancer
    Irina U. Agoulnik, Nancy L. Weigel · 2009 · Springer eBooks
  90. FMNL2/SRC-mediated androgen receptor translocation into the nucleus promotes enzalutamide resistance of prostate cancer
    Jianpeng Yu, Yukui Gao, Mingpeng Zhang, Yue Gao, Chun Wang, Yuanjie Niu, Zhiqun Shang · 2025 · iScience
  91. Steroid Receptor Coactivators (SRCs) as Integrators of Multiple Signaling Pathways in Cancer Progression
    Weiwen Long, Bert W. O’Malley · 2013 · Cancer drug discovery and develogment/Cancer drug discovery and development
  92. El cáncer de próstata resistente a castración. Mecanismos de progresión y nuevos tratamientos
    Alejandro Moro Soria, Celestino Laborí Carda, Antonio Bouzó López, Jorge González Hernández · 2012 · Revista Cubana de Urología
  93. Prostat Kanseri: Androjen Reseptörü Sinyal Mekanizması
    Yalçın Erzurumlu · 2020 · SDÜ Tıp Fakültesi Dergisi
  94. An Intensive Mind and Body Therapeutic Program Leads to Alteration in Gene Expression Critical to Aging Process in Peripheral Blood Stem Cells
    Krishna S. Rao, Swarup K. Chakrabarti, Vaishali S Dongare, B. S. Sharath, H. M. Vikas, K Chetana, Kaushik Dilip Deb · 2015 · Advances in Aging Research
  95. Androgen Receptor Biology in Prostate Cancer
    Edward Paul Gelmann · 2010 · Springer eBooks
  96. The Role of Androgen Receptor in Prostate Cancer
    Adeline Berger, David S. Rickman · 2017 · Molecular pathology library
  97. Molecular mechanism of prostate cancer cell apoptosis induced by busulfan via adjustment of androgen receptor phosphatization.
    Jun Liu, Guojun Jiang, Aiping Yang, Guohui Yang, Wenjuan Yang, Yi Fang · 2016 · PubMed Central
  98. Prostate Cancer Management: What Does the Future Hold?
    Bertrand F. TOMBAL · 2010 · European Urology Supplements
  99. Roles of novel post-translational modifications in the male reproductive system: From regulation of reproductive development to therapeutic potential
    Xin-Rong Du, Yan Gao, Qin Zeng, Guohui Zhang, Weixin Liu · 2025 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  100. The Role of Cyclic AMP in Regulating the Androgen Receptor
    Marianne D. Sadar · 2009 · Springer eBooks